Trump Nominates Surgeon Dr. Marty Makary as FDA Commissioner, Says He Will 'Course-Correct' the Agency

Nov.25.2024
Trump Nominates Surgeon Dr. Marty Makary as FDA Commissioner, Says He Will 'Course-Correct' the Agency
Trump nominates Johns Hopkins surgical oncologist and health policy expert Dr. Marty Makary for FDA Commissioner. Trump stated that FDA has lost sight of its primary regulatory goals. Dr. Makary, with his outstanding contributions to healthcare transparency and public health, will help refocus the agency and restore public trust.

President-elect Donald Trump recently announced on the social media platform Truth Social that he intends to nominate Dr. Martin Makary, a renowned pancreatic surgeon from Johns Hopkins University, as the Commissioner of FDA.

 

Trump Nominates Surgeon Dr. Marty Makary as FDA Commissioner, Says He Will 'Course-Correct' the Agency
Original statement | Image source: Truth Social

 

In his statement, Trump said, "FDA has lost the trust of Americans and has lost sight of its primary goal as a regulator. The Agency needs Dr. Marty Makary, a Highly Respected Johns Hopkins Surgical Oncologist and Health Policy Expert, to course-correct and refocus the Agency."

 

Trump Nominates Surgeon Dr. Marty Makary as FDA Commissioner, Says He Will 'Course-Correct' the Agency
Introduction on Johns Hopkins Hospital | Image source: Johns Hopkins University

 

 

About Dr. Marty Makary, according to the Johns Hopkins University website:

 

Dr. Marty Makary is a surgeon and public policy researcher at Johns Hopkins University. He writes for The Washington Post and The Wall Street Journal and is the author of two New York Times bestselling books, Unaccountable and The Price We Pay. Dr. Makary served in leadership at the World Health Organization Patient Safety Program and has been elected to the National Academy of Medicine.

 

Clinically, Dr. Makary is the chief of Islet Transplant Surgery at Johns Hopkins. He is the recipient of the Nobility in Science Award from the National Pancreas Foundation and has been a visiting professor at over 25 medical schools. He has published over 250 peer-reviewed scientific articles and has served on several editorial boards.

 

Dr. Makary is the recipient of the 2020 Business Book of the Year Award by the Association of Business Journalists for his most recent book, The Price We Pay. It has been described by Don Berwick as "a deep dive into the real issues driving up the price of health care" and by Steve Forbes as "A must-read for every American".

 

Dr. Makary serves as a professor at the Johns Hopkins School of Medicine and a professor, by courtesy, at the Johns Hopkins Carey Business School. His current research focuses on the underlying causes of disease, public policy, health care costs, and relationship-based medicine.

 

Cover image source: New York Times.

 

From Glo Hyper Pro to Industry Realignment: A Defining Move by BAT’s Former Design Head——For Jonathon Lister, good design starts not with form or flair—but with trust, ethics, and regulatory clarity
From Glo Hyper Pro to Industry Realignment: A Defining Move by BAT’s Former Design Head——For Jonathon Lister, good design starts not with form or flair—but with trust, ethics, and regulatory clarity
In an exclusive interview with 2Firsts, former BAT Design Director Jonathon Lister offers an in-depth analysis of the design philosophy and strategic thinking behind glo Hyper Pro. He advocates for design that builds trust, responds to regulation, and conveys values—arguing that the future of novel tobacco products lies not in manufacturing capability, but in cultural judgment and ethical awareness. This is not just the story of a product, but an attempt to reshape the industry's way of thinking
Jun.11
Exclusive Interview with Maskking: As the Screen Trend Fades, Brand Competition Will Return to “Product + Channel”
Exclusive Interview with Maskking: As the Screen Trend Fades, Brand Competition Will Return to “Product + Channel”
Maskking’s product manager Shane says the craze for touchscreens has become unnecessary. Instead, the brand uses an app to track vaping data and send user reminders, aiming to boost engagement and experience. Their disposable vapes focus on adjustable features for different needs. The U.S. remains a key market, and future competition will center on strong products and effective channels.
Jun.19 by 2FIRSTS.ai
Tobacco Giants Speak on THR at GFN: Calling for Regulatory Reform Aligned with Scientific Understanding
Tobacco Giants Speak on THR at GFN: Calling for Regulatory Reform Aligned with Scientific Understanding
At the GFN 2025, representatives from the world’s four largest tobacco companies emphasized the need for science-driven harm reduction policies. They urged regulators to move beyond outdated approaches and adopt consumer-focused, evidence-based frameworks to better serve public health goals.
Jun.26
Philip Morris International invests in smoke-free electronic devices to reduce health risks.
Philip Morris International invests in smoke-free electronic devices to reduce health risks.
PMI invests in smoke-free electronic devices to reduce health risks caused by tobacco combustion, facing regulatory challenges and black market effects.
Jun.12 by 2FIRSTS.ai
Philip Morris International Reports Q2 2025 Results: Revenue Reaches $10.14 Billion as Smoke-Free Products Rise to 41% of Total Sales
Philip Morris International Reports Q2 2025 Results: Revenue Reaches $10.14 Billion as Smoke-Free Products Rise to 41% of Total Sales
On July 22, Philip Morris International (PMI) reported Q2 2025 earnings with net revenue of $10.14 billion, up 7.1% year-over-year. Smoke-free product revenue reached $4.2 billion (41% of total), growing 14.5% organically. Heated tobacco shipments hit 38.8 billion units; e-vapor shipments more than doubled; nicotine pouch volume rose 43.3%. IQOS market share in Japan climbed to 31.7%. PMI raised its full-year EPS guidance to $7.24–$7.37.
Jul.22
UK Study: Teen Vaping Rates Rise to Levels Last Seen in the 1970s
UK Study: Teen Vaping Rates Rise to Levels Last Seen in the 1970s
A new UK study finds that teen smoking rates among e-cigarette users have returned to levels seen in the 1970s, raising concerns that vaping may lead to nicotine addiction. Although youth smoking declined significantly over the past 50 years, one-third of teen vapers still continue to smoke.
Jul.30 by 2FIRSTS.ai